Alexander A. Kremzer

944 total citations
45 papers, 625 citations indexed

About

Alexander A. Kremzer is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Immunology. According to data from OpenAlex, Alexander A. Kremzer has authored 45 papers receiving a total of 625 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 19 papers in Cardiology and Cardiovascular Medicine and 12 papers in Immunology. Recurrent topics in Alexander A. Kremzer's work include Extracellular vesicles in disease (14 papers), Cardiovascular Disease and Adiposity (9 papers) and Biomarkers in Disease Mechanisms (9 papers). Alexander A. Kremzer is often cited by papers focused on Extracellular vesicles in disease (14 papers), Cardiovascular Disease and Adiposity (9 papers) and Biomarkers in Disease Mechanisms (9 papers). Alexander A. Kremzer collaborates with scholars based in Ukraine, Czechia and Australia. Alexander A. Kremzer's co-authors include Alexander Е. Berezin, Tetiana A. Berezina, Yulia V. Martovitskaya, Peter Kružliak, Anthony Zulli, Ján Klimas, Ján Sabó, Nieves Martell‐Claros, Daniel Petrovič and Giovanni Cammarota and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Cardiovascular Research.

In The Last Decade

Alexander A. Kremzer

44 papers receiving 573 citations

Peers

Alexander A. Kremzer
Judith J. de Haan Netherlands
Hui Yuan China
Abraham Behrmann United States
Nwe Nwe Soe United States
Wouter Verhesen Netherlands
Ane Salvador United States
Alexander A. Kremzer
Citations per year, relative to Alexander A. Kremzer Alexander A. Kremzer (= 1×) peers Cheng Qian

Countries citing papers authored by Alexander A. Kremzer

Since Specialization
Citations

This map shows the geographic impact of Alexander A. Kremzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander A. Kremzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander A. Kremzer more than expected).

Fields of papers citing papers by Alexander A. Kremzer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander A. Kremzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander A. Kremzer. The network helps show where Alexander A. Kremzer may publish in the future.

Co-authorship network of co-authors of Alexander A. Kremzer

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander A. Kremzer. A scholar is included among the top collaborators of Alexander A. Kremzer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander A. Kremzer. Alexander A. Kremzer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hart, Phil A., Raj J. Shah, José Nieto, et al.. (2023). A Randomized Controlled Phase 2 Dose-Finding Trial to Evaluate the Efficacy and Safety of Camostat in the Treatment of Painful Chronic Pancreatitis: The TACTIC Study. Gastroenterology. 166(4). 658–666.e6. 9 indexed citations
2.
Kružliak, Peter, Alexander Е. Berezin, Alexander A. Kremzer, et al.. (2016). Global Longitudinal Strain and Strain Rate in Type Two Diabetes Patients with Chronic Heart Failure: Relevance to Osteoprotegerin. Folia Medica. 58(3). 164–173. 5 indexed citations
3.
Berezin, Alexander Е., et al.. (2016). Circulating thrombospondin-2 in patients with moderate-to-severe chronic heart failure due to coronary artery disease. Journal of Biomedical Research. 30. 32–39. 8 indexed citations
6.
Berezin, Alexander Е., et al.. (2016). An association of serum vistafin level and number of circulating endothelial progenitor cells in type 2 diabetes mellitus patients. Diabetes & Metabolic Syndrome Clinical Research & Reviews. 10(4). 205–212. 16 indexed citations
7.
Berezin, Alexander Е. & Alexander A. Kremzer. (2015). Predictive value of circulating osteonectin in patients with ischemic symptomatic chronic heart failure. Biomedical Journal. 38(6). 523–530. 9 indexed citations
8.
Berezin, Alexander Е. & Alexander A. Kremzer. (2015). Content of Circulating Endothelial Progenitor Cells in Patients With Chronic Ischemic Heart Failure With Preserved Left Ventricular Ejection Fraction. Kardiologiia. 1_2015(1). 14–22. 3 indexed citations
9.
Berezin, Alexander Е., et al.. (2015). Pattern of circulating endothelial-derived microparticles among chronic heart failure patients with dysmetabolic comorbidities: The impact of subclinical hypothyroidism. Diabetes & Metabolic Syndrome Clinical Research & Reviews. 10(1). 29–36. 12 indexed citations
10.
Berezin, Alexander Е., et al.. (2015). Impaired immune phenotype of circulating endothelial-derived microparticles in patients with metabolic syndrome and diabetes mellitus. Journal of Endocrinological Investigation. 38(8). 865–874. 49 indexed citations
11.
Berezin, Alexander Е., Alexander A. Kremzer, Tetiana A. Berezina, & Yulia V. Martovitskaya. (2015). Pattern of circulating microparticles in chronic heart failure patients with metabolic syndrome: Relevance to neurohumoral and inflammatory activation. PubMed. 4. 69–75. 32 indexed citations
12.
Berezin, Alexander Е. & Alexander A. Kremzer. (2014). Relationship Between Serum RANKL/Osteoprotegerin Complex and Endothelial Progenitor Cells in Ischemic Chronic Heart Failure. 1(8). 189–195. 2 indexed citations
13.
Berezin, Alexander Е., Alexander A. Kremzer, & Yulia V. Martovitskaya. (2014). Apoptotic Microparticles as Predicted Biomarkers in Patients with Chronic Heart Failure — Relevance to Inflammatory Cytokines and Outcomes. 3(1). 1 indexed citations
14.
Berezin, Alexander Е. & Alexander A. Kremzer. (2014). Relationship between circulating endothelial progenitor cells and insulin resistance in non-diabetic patients with ischemic chronic heart failure. Diabetes & Metabolic Syndrome Clinical Research & Reviews. 8(3). 138–144. 17 indexed citations
16.
Berezin, Alexander Е. & Alexander A. Kremzer. (2014). Circulating Endothelial Progenitor Cells as Markers for Severity of Ischemic Chronic Heart Failure. Journal of Cardiac Failure. 20(6). 438–447. 33 indexed citations
17.
Berezin, Alexander Е., et al.. (2014). The predictive role of circulating microparticles in patients with chronic heart failure. PubMed. 3. 18–24. 33 indexed citations
18.
Berezin, Alexander Е., et al.. (2014). The effect of angiotensin-2 receptor blocker valsartan on circulating level of endothelial progenitor cells in diabetic patients with asymptomatic coronary artery disease. Diabetes & Metabolic Syndrome Clinical Research & Reviews. 9(4). 305–309. 7 indexed citations
19.
Berezin, Alexander Е., et al.. (2014). Serum Uric Acid Predicts Declining of Circulating Proangiogenic Mononuclear Progenitor Cells in Chronic Heart Failure Patients. Journal of Cardiovascular and Thoracic Research. 6(3). 153–162. 16 indexed citations
20.
Berezin, Alexander Е. & Alexander A. Kremzer. (2013). Circulating osteopontin as a marker of early coronary vascular calcification in type two diabetes mellitus patients with known asymptomatic coronary artery disease. Atherosclerosis. 229(2). 475–481. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026